Appendix 3B & S708A Cleansing Notice
Download the PDFPreparing the document viewer…
Read the announcement as text
1 August 2019
Placement Shares allotted & Notice pursuant to S708A(5)(e) of the
Corporations Act 2001 S708A Cleansing Notice
The Agency Group Australia (ASX: AU1) (“The Agency” or “the Company), today announces that the
Placement to Magnolia Capital and Honan Insurance Group has been fully completed with
16,923,077 Ordinary Shares issued and allotted.
The Company gives this notice pursuant to section 708A(5)(e) of the Corporations Act 2001 (Cth)
(“Act”). The Company has completed a private placement to sophisticated investors to raise $1.1M
at a price of $0.065 by way of a private placement (“Placement”).
The Company has issued fully paid ordinary shares (“Shares”) in the capital of the Company as per
the Appendix 3B accompanied by this notice.
The Company advises that the Shares were issued without disclosure to investors under Part 6D.2
of the Act. The Company, as at the date of this notice, has complied with:
• the provisions of Chapter 2M of the Act as they apply to the Company; and
• section 674 of the Act.
As at the date of this notice there is no information that is excluded information for the purposes
of sections 708A(7) and (8) of the Act.
The new capital structure of the Company is:
Quoted Un-Quoted Total
Ordinary Shares 120,733,124 - 120,733,124
Options (4c) Exp 19/12/2019 - 1,722,222 1,722,222
Options (2c) Exp 28/12/2019 - 3,200,023 3,200,023
Options (4c) Exp 20/12/2020 - 66,667 66,667
Options (2.5c) Exp 20/12/2020 - 266,667 266,667
Options (30c) Exp 11/01/2022 - 333,333 333,333
Vendor Performance Rights 2,222,251 2,222,251
Incentive Performance Shares 1,555,558 1,555,558
130,099,845
Your faithfully
Stuart Usher
Company Secretary
The Agency Group Australia Ltd
Appendix 3B
New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional
securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents
given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
THE AGENCY GROUP AUSTRALIA LIMITED
ABN
52 118 913 232
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued or to be issued Ordinary Fully Paid Shares
2 Number of +securities issued or to be 16,923,077 Ordinary Fully Paid Shares
issued (if known) or maximum number
which may be issued
3 Principal terms of the +securities (e.g. if -
options, exercise price and expiry date; if
partly paid +securities, the amount
outstanding and due dates for payment; if
+convertible securities, the conversion
price and dates for conversion)
4 Do the +securities rank equally in all
respects from the +issue date with an Ordinary Fully Paid shares – yes
existing +class of quoted +securities?
If the additional +securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate for
the next dividend, (in the case of a
trust, distribution) or interest payment
• the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 1
Appendix 3B
New issue announcement
5 Issue price or consideration Ordinary Fully Paid Shares $1,100,000 (6.5 cents per
share)
6 Purpose of the issue Share Placement at an issue price of $0.065 together
(If issued as consideration for the with one (1) free Attaching Option for every two (2)
acquisition of assets, clearly identify those Placement Shares. (NOTE – the options will be issued
assets) subject to receiving shareholder approval at a
General Meeting to be convened shortly)
6a Is the entity an +eligible entity that has Yes
obtained security holder approval under
rule 7.1A?
If Yes, complete sections 6b – 6h in relation
to the +securities the subject of this
Appendix 3B, and comply with section 6i
6b The date the security holder resolution 28 November 2018
under rule 7.1A was passed
6c Number of +securities issued without 15,571,507
security holder approval under rule 7.1
6d Number of +securities issued with security 1,351,570
holder approval under rule 7.1A
6e Number of +securities issued with security Nil
holder approval under rule 7.3, or another
specific security holder approval (specify
date of meeting)
6f Number of +securities issued under an Nil
exception in rule 7.2
6g If +securities issued under rule 7.1A, was Yes.
issue price at least 75% of 15 day VWAP as VWAP $0.0762, 75% of 15 day VWAP $0.0571, as at 31-
calculated under rule 7.1A.3? Include the Aug 2019
+issue date and both values. Include the (Source: Capital IQ)
source of the VWAP calculation.
6h If +securities were issued under rule 7.1A N/A
for non-cash consideration, state date on
which valuation of consideration was
released to ASX Market Announcements
+ See chapter 19 for defined terms.
Appendix 3B Page 2
04/03/201
3
Appendix 3B
New issue announcement
6i Calculate the entity’s remaining issue 7.1 -
capacity under rule 7.1 and rule 7.1A –
7.1A 9,029,435
complete Annexure 1 and release to ASX
Market Announcements
7
7 +Issue dates 1 August 2019
Note: The issue date may be prescribed by ASX (refer to the
definition of issue date in rule 19.12). For example, the issue
date for a pro rata entitlement issue must comply with the
applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
Number
+Class
8 Number and +class of all +securities quoted 120,733,124 Ordinary Shares
on ASX (including the +securities in section
2 if applicable)
Number
+Class
9 Number and +class of all +securities not
10 quoted on ASX (including the securities in
section 2 if applicable) 1,722,222 Options @ $0.04
Number and +class of all +securities not expiring 19-Dec 2019
quoted on ASX (including the securities in 3,200,023 Options @ $0.02
section 2 if applicable) expiring 28 Dec 2019
Dividend policy (in the case of a trust, 66,667 Options @ $0.04
distribution policy) on the increased capital expiring 20-Dec 2020
(interests) 266,667 Options @ $0.025
expiring 20-Dec 2020
333,333 Options @ $0.30
expiring 11-Jan-2022
2,222,251 Vendor Performance Shares
1,555,558 Incentive Performance
Shares
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 3
Appendix 3B
New issue announcement
Part 2 - Pro rata issue
11 Is security holder approval required? -
12 Is the issue renounceable or -
non-renounceable?
13 Ratio in which the +securities will be offered -
14 +Class of +securities to which the offer -
relates
15 +Record date to determine entitlements -
16 Will holdings on different registers (or sub- -
registers) be aggregated for calculating
entitlements?
17 Policy for deciding entitlements in relation -
to fractions
18 Names of countries in which the entity has -
security holders who will not be sent new
offer documents
Note: Security holders must be told how their entitlements are
to be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt of acceptances or N/A
renunciations
20 Names of any underwriters N/A
21 Amount of any underwriting fee or N/A
commission
22 Names of any brokers to the issue N/A
23 Fee or commission payable to the broker to N/A
the issue
24 Amount of any handling fee payable to N/A
brokers who lodge acceptances or
renunciations on behalf of security holders
25 If the issue is contingent on security holders’ N/A
approval, the date of the meeting
26 Date entitlement and acceptance form and N/A
offer documents will be sent to persons
entitled
+ See chapter 19 for defined terms.
Appendix 3B Page 4
04/03/201
3
Appendix 3B
New issue announcement
27 If the entity has issued options, and the N/A
terms entitle option holders to participate
on exercise, the date on which notices will
be sent to option holders
28 Date rights trading will begin (if applicable) N/A
29 Date rights trading will end (if applicable) N/A
30 How do security holders sell their N/A
entitlements in full through a broker?
31 How do security holders sell part of their N/A
entitlements through a broker and accept
for the balance?
32 How do security holders dispose of their N/A
entitlements (except by sale through a
broker)?
33 +Issue date -
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) ☒
+Securities described in Part 1
(b) ☐ All other +securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share
securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 If the +securities are +equity securities, the names of the 20 largest holders of the additional
☐ +securities, and the number and percentage of additional +securities held by those holders
36 If the +securities are +equity securities, a distribution schedule of the additional +securities
☐ setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
☐
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 5
Appendix 3B
New issue announcement
Entities that have ticked box 34(b)
38 Number of +securities for which +quotation -
is sought
39 +Class of +securities for which quotation is -
sought
40 Do the +securities rank equally in all -
respects from the +issue date with an
existing +class of quoted +securities?
If the additional +securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate for
the next dividend, (in the case of a trust,
distribution) or interest payment
• the extent to which they do not rank
equally, other than in relation to the
next dividend, distribution or interest
payment
41 Reason for request for quotation now
Example: In the case of restricted securities, end of restriction -
period
(if issued upon conversion of another
+security, clearly identify that other
+security)
Number +Class
42 Number and +class of all +securities quoted 120,733,124 Ordinary Shares
on ASX (including the +securities in clause
38)
43
Quotation agreement
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on
any conditions it decides.
2 We warrant the following to ASX.
• The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
• There is no reason why those +securities should not be granted +quotation.
• An offer of the +securities for sale within 12 months after their issue will not require disclosure under
section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by
us in relation to any +securities to be quoted and that no-one has any right to return any +securities
to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request
that the +securities be quoted.
+ See chapter 19 for defined terms.
Appendix 3B Page 6
04/03/201
3
Appendix 3B
New issue announcement
• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under
section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense
arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is
not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge
that ASX is relying on the information and documents. We warrant that they are (will be) true and
complete.
Sign here: Date 1 August 2019
Print name: STUART USHER
Company Secretary
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 7
Appendix 3B
New issue announcement
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for
eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
STEP 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insert number of fully paid ordinary securities on issue 12 months 22,793,101
before date of issue or agreement to issue
Add the following:
• Number of fully paid ordinary securities issued in that 12 month 13,676,946
period under an exception in rule 7.2
• Number of fully paid ordinary securities issued in that 12 month 67,340,000
period with shareholder approval
• Number of partly paid ordinary securities that became fully paid in
that 12 month period
Note:
• Include only ordinary securities here – other classes of equity securities cannot be
added
• Include here (if applicable) the securities the subject of the Appendix 3B to which this
form is annexed
• It may be useful to set out issues of securities on different dates as separate line items
Subtract the number of fully paid ordinary securities cancelled during -
that 12 month period
“A” 103,810,047
STEP 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “ A ” b y 0 . 1 5 15,571,507
STEP 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used
Insert number of equity securities issued or agreed to be issued in
that 12 month period not counting those issued: 15,571,507
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless specifically excluded – not just ordinary
securities
• Include here (if applicable ) the securities the subject of the Appendix 3B to which this
form is annexed
• It may be useful to set out issues of securities on different dates as separate line items
“C” 15,571,507
+ See chapter 19 for defined terms.
Appendix 3B Page 8
04/03/201
3
Appendix 3B
New issue announcement
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 15,571,507
Note: number must be same as shown in Step 2
Subtract “C” (15,571,507)
Note: number must be same as shown in Step 3
Total [ “ A ” x 0 . 1 5 ] – “ C ” -
[Note: this is the remaining placement
capacity under rule 7.1]
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
“A” 103,810,047
Note: number must be same as shown in Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
[Note: this value cannot be changed]
Multiply “ A ” b y 0 . 1 0 10,381,005
Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used
Insert number of equity securities issued or agreed to be issued in 1,351,570
that 12 month period under rule 7.1A
Notes:
• This applies to equity securities – not just ordinary securities
• Include here – if applicable – the securities the subject of the Appendix 3B to which
this form is annexed
• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part
1), or for which specific security holder approval has been obtained
• It may be useful to set out issues of securities on different dates as separate line items
“E” 1,381,005
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 10,381,005
Note: number must be same as shown in Step 2
Subtract “E” (1,381,005)
Note: number must be same as shown in Step 3
Total [ “ A ” x 0 . 1 0 ] – “ E ” 9,029,435
[Note: this is the remaining placement
capacity under rule 7.1A]
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 9